News & Updates

The use of continuous positive airway pressure (CPAP) significantly reduces the risk of tracheal intubation and mortality among hospitalized patients with COVID-19–related acute hypoxemic respiratory failure, according to the RECOVERY-RS* trial.

While tolvaptan does not seem to provide a clear economic benefit in all patients with chronic heart failure (CHF), its use in those who require high-dose furosemide may be cost-effective, a recent study has found.

Patients with COVID-19 who received mechanical ventilation while admitted to the intensive care unit (ICU) have an elevated risk of invasive fungal infections (IFIs), according to results of the MYCOVID study from France. Furthermore, patients with COVID-19–associated pulmonary aspergillosis (CAPA) may be at an increased risk for death.

Adherence to lenalidomide is remarkably lacking among patients with multiple myeloma at 1 year following treatment initiation, a study has found.

The implementation of nonpharmaceutical interventions (NPIs) during the COVID-19 pandemic has significantly reduced the incidences of S. pneumoniae and Salmonella spp. among nine major pathogens of invasive bacterial infection (IBI) in children, reports a study.

Habitual consumption of coffee may be protective against Alzheimer’s disease (AD), suggests a longitudinal study from Australia.

Prenatal maternal anxiety is correlated with markers of epigenetic age acceleration in male infants, irrespective of other genetic, socioeconomic, or obstetric risk factors, according to a recent study